Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Hisahiko Motohashi"'
Autor:
Toshio Imada, Hiroyuki Saeki, Shoji Takemiya, Roppei Yamada, Hisahiko Motohashi, Makoto Akaike, Manabu Shiozawa, Yukio Sugimasa
Publikováno v:
The Japanese Journal of Gastroenterological Surgery. 38:289-294
はじめに: 大腸癌根治手術後の早期再発発見を目的としたintensive follow up法の妥当性を検討した. 対象および方法: 1986~2001年までの大腸癌根治度A症例のうち単発再発を認めた126例を対象と
Autor:
S. Rodenhuis, Laszlo Nehéz, Giuseppe Mascetta, P. Steenvoorde, Giovanni Butturini, L. Krähenbühl, Koichi Nagata, Hideaki Andoh, Yoshihiro Asanuma, Shin-ei Kudo, Tsutomu Yoshida, Ouki Yasui, R.J. de Vos tot Nederveen Cappel, Claudio Bassi, Brian J. Rowlands, J.L. Peterse, Yohei Miyagi, W.J. Vles, Pravin J. Gupta, Noriyuki Hirahara, R. van Hillegersberg, R. Vonlanthen, H.J.M. Oostvogel, Enrico Molinari, F.J. Vogelaar, Masato Yoshioka, Paolo Pederzoli, Kenji Koyama, Jenny Johansson, Hitoshi Kotanagi, W.C.J. Hop, J.M. Michel, George Tzovaras, W.H. Schreurs, Yoshinori Nio, K. Bosscha, Norihito Ise, Osamu Kobayashi, Kazushige Yamaguchi, Thomas Diamond, U. Giger, Toshiaki Kurokawa, Akira Tsuburaya, Satoshi Shibata, Hisahiko Motohashi, Yuka Sugiyama, R.A.E.M. Tollenaar, Bobby Tingstedt, F. van Coevorden, W.H.N.M. Stuifbergen, Tsutomu Sato, J. Jeekel, H.G. Gooszen, Toshio Imada, J. Oskam, L. P. van Minnen, Andrew A. Gumbs, Roberto Salvia, Motonori Sairenji, Rowan W. Parks, Go Watanabe, Roland Andersson, Haruhiko Cho, M.G.H. Besselink, D.J. Swank, M.E.I. Schipper, Masayuki Itakura, M. S. van Leeuwen, Massimo Falconi
Publikováno v:
Digestive Surgery. 21:12-22
Autor:
Atsushi Nashimoto, Hisahiko Motohashi, Mitsuru Sasako, Yoshitaka Yamamura, Seiichiro Yamamoto, Hiroshi Furukawa, Toshifusa Nakajima, Masatsugu Kitamura, Taira Kinoshita, Yasuo Kunii
Publikováno v:
Journal of Clinical Oncology. 21:2282-2287
Purpose: To evaluate the survival benefit of adjuvant chemotherapy after curative resection in serosa-negative gastric cancer patients (excluding patients who were T1N0), we conducted a multicenter phase III clinical trial in which 13 cancer centers
Autor:
Hisahiko Motohashi, Toshio Imada, Motonori Sairenji, Kazuo Konishi, Osamu Kobayashi, Akira Tsuburaya, Haruhiko Cho
Publikováno v:
Gastric Cancer. 6:24-27
An oral tegafur compound, S-1 (TS-1), was developed to potentiate antitumor activity and to reduce gastrointestinal toxicities for patients with gastric cancer. It has achieved a high response rate against advanced and recurrent gastric cancer (ARGC)
Autor:
Haruhiko Cho, Osamu Kobayashi, Takaki Yoshikawa, Akira Tsuburaya, Yuka Sugiyama, Hisahiko Motohashi, Motonori Sairenji
Publikováno v:
International Journal of Clinical Oncology. 8:67-71
Background: The aim of this study was to determine the treatment strategy for ovarian metastases from gastric cancer, by a retrospective study of the treatment results. Methods: We reviewed the records of patients with ovarian metastases from primary
Autor:
Toshio Imada, Manabu Shiozawa, Yukio Sugimasa, Makoto Akaike, Roppei Yamada, Syoji Takemiya, Haruhiko Nakayama, Hisahiko Motohashi, Hiroyuki Saeki
Publikováno v:
Nihon Gekakei Rengo Gakkaishi (Journal of Japanese College of Surgeons). 28:686-689
Autor:
Yoshikazu Noguchi, Hisahiko Motohashi, Motonori Sairenji, Takaki Yoshikawa, Osamu Kobayashi, Akira Tsuburaya
Publikováno v:
Annals of Surgical Oncology. 9:401-405
The objective of this study was to clarify a survival benefit of D2 lymphadenectomy in patients with early gastric carcinoma (GC). A retrospective study was conducted to examine the incidence of metastasis to level 2 lymph nodes, the causes of postop
Autor:
Hisahiko Motohashi, Haruhiko Cho, Kazuo Konishi, Akira Tsuburaya, Masahiro Kanari, Osamu Kobayashi, Takaki Yoshikawa, Motonori Sairenji
Publikováno v:
Gastric Cancer. 5:47-50
We report a patient with peritoneal metastases who was successfully treated with a novel oral fluoropyrimidine anticancer drug, TS-1, as first-line chemotherapy. The patient was a 72-year-old man who had undergone curative resection for type 4 gastri
Autor:
Akira Tsuburaya, Motonori Sairenji, Hisahiko Motohashi, Masahiro Kanari, Takaki Yoshikawa, Osamu Kobayashi
Publikováno v:
The Japanese Journal of Gastroenterological Surgery. 34:1501-1505
胃癌再発例の病態は多様であり, 再発後の予後因子は明確ではない. そこで胃癌再発例に対する再発腫瘍摘除の予後因子としての意義を再発後生存期間から検討した. 対象は1986年から2000
Autor:
Osamu Kobayashi, Takaki Yoshikawa, Hisahiko Motohashi, Yoshikazu Noguchi, Akira Tsuburaya, Shunsuke Yanoma, Motonori Sairenji
Publikováno v:
Cancer Letters. 153:7-12
We examined plasma levels of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) in 54 patients with gastric carcinoma. Postoperative survival was significantly poorer in patients with plasma VEGF levels more than 10.0